CSPC Pharmaceutical Group announces FDA approval for clinical trial of its octreotide long-acting injection SYHX2008 in the US.
Jin1006/18, 04:42 PM
Related assets
Coming up for 01093.HK
Explore next
Latest 01093.HK news
Jin1008/20, 11:21 AM
Jin1008/13, 09:41 AM
Jin1007/30, 08:19 AM